Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028228429> ?p ?o ?g. }
- W2028228429 endingPage "11400" @default.
- W2028228429 startingPage "11400" @default.
- W2028228429 abstract "To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular carcinoma.Thirty-nine patients (mean age 55 years, males: 32) with decompensated liver cirrhosis and refractory ascites were enrolled. All patients received a combination of tolvaptan (15 mg/d for 5-14 d) and diuretics (40-80 mg/d of furosemide and 80-160 mg/d of spironolactone). The etiology of cirrhosis included hepatitis B (69.2%), hepatitis C (7.7%) and alcohol-induced (23.1%). Changes in the urine excretion volume, abdominal circumference and edema were assessed. The serum sodium levels were also measured, and adverse events were recorded. A follow-up assessment was conducted 1 mo after treatment with tolvaptan.Tolvaptan increased the mean urine excretion volume (1969.2 ± 355.55 mL vs 3410.3 ± 974.1 mL, P < 0.001), and 89.7% of patients showed improvements in their ascites, 46.2% of whom showed significant improvements. The overall efficacy of tolvaptan in all patients was 89.7%; the efficacies in patients with hepatocellular carcinoma and hepatorenal syndrome were 84.2% and 77.8%, respectively. The incidence of hyponatremia was 53.8%. In patients with hyponatremia, the serum sodium levels increased after tolvaptan treatment (from 128.1 ± 4.22 mEq/L vs 133.1 ± 3.8 mEq/L, P < 0.001). Only mild drug-related adverse events, including thirst and dry mouth, were observed.Tolvaptan is a promising aquaretic for the treatment of refractory ascites in patients with decompensated liver cirrhosis." @default.
- W2028228429 created "2016-06-24" @default.
- W2028228429 creator A5006651636 @default.
- W2028228429 creator A5015636491 @default.
- W2028228429 creator A5024479325 @default.
- W2028228429 creator A5044741816 @default.
- W2028228429 creator A5047884370 @default.
- W2028228429 creator A5064038450 @default.
- W2028228429 creator A5071458554 @default.
- W2028228429 creator A5074494657 @default.
- W2028228429 creator A5083581319 @default.
- W2028228429 creator A5087243462 @default.
- W2028228429 date "2014-01-01" @default.
- W2028228429 modified "2023-09-24" @default.
- W2028228429 title "Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients" @default.
- W2028228429 cites W1576049281 @default.
- W2028228429 cites W1773606155 @default.
- W2028228429 cites W1999518404 @default.
- W2028228429 cites W2003790768 @default.
- W2028228429 cites W2005233497 @default.
- W2028228429 cites W2046490966 @default.
- W2028228429 cites W2051695460 @default.
- W2028228429 cites W2053130072 @default.
- W2028228429 cites W2053200344 @default.
- W2028228429 cites W2062255892 @default.
- W2028228429 cites W2065182626 @default.
- W2028228429 cites W2068254183 @default.
- W2028228429 cites W2100135543 @default.
- W2028228429 cites W2112643254 @default.
- W2028228429 cites W2113495970 @default.
- W2028228429 cites W2120040647 @default.
- W2028228429 cites W2123312350 @default.
- W2028228429 cites W2134850869 @default.
- W2028228429 cites W2148609006 @default.
- W2028228429 cites W2161838161 @default.
- W2028228429 cites W2163403599 @default.
- W2028228429 cites W2169318640 @default.
- W2028228429 cites W2184687942 @default.
- W2028228429 cites W4247209357 @default.
- W2028228429 cites W4254004742 @default.
- W2028228429 doi "https://doi.org/10.3748/wjg.v20.i32.11400" @default.
- W2028228429 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4145782" @default.
- W2028228429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25170228" @default.
- W2028228429 hasPublicationYear "2014" @default.
- W2028228429 type Work @default.
- W2028228429 sameAs 2028228429 @default.
- W2028228429 citedByCount "35" @default.
- W2028228429 countsByYear W20282284292015 @default.
- W2028228429 countsByYear W20282284292016 @default.
- W2028228429 countsByYear W20282284292017 @default.
- W2028228429 countsByYear W20282284292018 @default.
- W2028228429 countsByYear W20282284292019 @default.
- W2028228429 countsByYear W20282284292020 @default.
- W2028228429 countsByYear W20282284292021 @default.
- W2028228429 countsByYear W20282284292022 @default.
- W2028228429 countsByYear W20282284292023 @default.
- W2028228429 crossrefType "journal-article" @default.
- W2028228429 hasAuthorship W2028228429A5006651636 @default.
- W2028228429 hasAuthorship W2028228429A5015636491 @default.
- W2028228429 hasAuthorship W2028228429A5024479325 @default.
- W2028228429 hasAuthorship W2028228429A5044741816 @default.
- W2028228429 hasAuthorship W2028228429A5047884370 @default.
- W2028228429 hasAuthorship W2028228429A5064038450 @default.
- W2028228429 hasAuthorship W2028228429A5071458554 @default.
- W2028228429 hasAuthorship W2028228429A5074494657 @default.
- W2028228429 hasAuthorship W2028228429A5083581319 @default.
- W2028228429 hasAuthorship W2028228429A5087243462 @default.
- W2028228429 hasBestOaLocation W20282284291 @default.
- W2028228429 hasConcept C126322002 @default.
- W2028228429 hasConcept C197934379 @default.
- W2028228429 hasConcept C2776703092 @default.
- W2028228429 hasConcept C2776988256 @default.
- W2028228429 hasConcept C2777214474 @default.
- W2028228429 hasConcept C2777482430 @default.
- W2028228429 hasConcept C2777955127 @default.
- W2028228429 hasConcept C2778019345 @default.
- W2028228429 hasConcept C2780496750 @default.
- W2028228429 hasConcept C2780615674 @default.
- W2028228429 hasConcept C71924100 @default.
- W2028228429 hasConcept C90924648 @default.
- W2028228429 hasConceptScore W2028228429C126322002 @default.
- W2028228429 hasConceptScore W2028228429C197934379 @default.
- W2028228429 hasConceptScore W2028228429C2776703092 @default.
- W2028228429 hasConceptScore W2028228429C2776988256 @default.
- W2028228429 hasConceptScore W2028228429C2777214474 @default.
- W2028228429 hasConceptScore W2028228429C2777482430 @default.
- W2028228429 hasConceptScore W2028228429C2777955127 @default.
- W2028228429 hasConceptScore W2028228429C2778019345 @default.
- W2028228429 hasConceptScore W2028228429C2780496750 @default.
- W2028228429 hasConceptScore W2028228429C2780615674 @default.
- W2028228429 hasConceptScore W2028228429C71924100 @default.
- W2028228429 hasConceptScore W2028228429C90924648 @default.
- W2028228429 hasIssue "32" @default.
- W2028228429 hasLocation W20282284291 @default.
- W2028228429 hasLocation W20282284292 @default.
- W2028228429 hasLocation W20282284293 @default.
- W2028228429 hasLocation W20282284294 @default.
- W2028228429 hasOpenAccess W2028228429 @default.